Q STATE BIOSCIENCES INC has a total of 11 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are Q-STATE BIOSCIENCES INC, MICROBIX BIOSYSTEMS INC and BIOTRIN INTELLECTUAL PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Canada | 1 | |
#4 | Japan | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Optics |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Optical systems |
# | Name | Total Patents |
---|---|---|
#1 | Werley Christopher | 6 |
#2 | Cohen Adam | 5 |
#3 | Kralj Joel | 4 |
#4 | Eggan Kevin C | 3 |
#5 | Kiskinis Evangelos | 3 |
#6 | Mcmanus Owen | 3 |
#7 | Malmberg Annika | 3 |
#8 | Wasserman Steven | 2 |
#9 | Adam Cohen | 1 |
#10 | Cottrell Jeffrey R | 1 |
Publication | Filing date | Title |
---|---|---|
CA3055916A1 | Pain response mediator compositions and methods for making and using same | |
US2016266144A1 | Cardiotoxicity screening methods |